No Data
A-share brain-computer interface concept rises and soars, innovative medical management hits the limit up.
Gelonghui November 4th | Innovative Medical Management hit the daily limit, Sanbo Neurology, Beijing Chieftain Control Engineering Technology, Chengdu Information Technology of Chinese Academy of Sciences, and Xiangyu Medical followed the uptrend.
Sanbo Neurology: Report for the third quarter of 2024
Sanbo Brain Science (301293.SZ) released its performance for the first three quarters, with a net income of 0.105 billion yuan, a year-on-year increase of 42.93%.
Sanbo Brain (301293.SZ) released the third quarter report of 2024, with revenue for the first three quarters reaching 10...
Sanbo Brain (301293.SZ): Intends to acquire 70% equity of Dayou Guangze by way of capital increase and equity acquisition.
Gelonghui September 27 | Sanbo Brain Health (301293.SZ) announced plans to use its own funds, over-raised funds, and interest generated from fundraising totaling 0.42 billion yuan to increase the capital of its wholly-owned subsidiary Sanbo (Chongqing) Property Management Co., Ltd. (referred to as 'Chongqing Sanbo'), invest in sichuan Dahang Guangze Medical Investment Management Co., Ltd. (referred to as 'Dahang Guangze' 'Target Company') by Chongqing Sanbo, this investment is intended to acquire 70% equity of Dahang Guangze through capital increase and equity transfer. The target company holds 100% equity of Chengdu Dongli Hospital Co., Ltd., and Chengdu Dongli Hospital operates as a tertiary comprehensive hospital.
Express News | San Bao Brain: intends to increase capital by 0.42 billion yuan to purchase 70% equity of Da Hang Guangze, a wholly-owned subsidiary.
Sanby Nuer (301293.SZ) repurchased 1.46% of the shares, costing 0.104 billion yuan.
Sanbo Brain (301293.SZ) announced that as of August 31, 2024, the company traded through centralized auction. ...
No Data
No Data